The World Evidence, Pricing and Access Congress has taken place in Amsterdam, working to help healthcare experts get the most from their resources in 2025. Leading two sessions at the event was Fernando Ventureira, CEO of Stratence Partners.
World Evidence, Pricing and Access (EPA) Congress is Europe’s largest annual gathering of market access, pricing, and evidence professionals. Taking place in March 2025, this year’s event was staged at the RAI Congress Centre in Amsterdam, hosting over 250 speakers and attracting more than 1,500 attendees from the pharmaceutical, biotech, and payer sectors.
With healthcare professionals facing shortfalls in funding, and pharmaceutical and research players under pressure to help address a number of global health concerns, the 2025 edition of the World EPA Congress offered a two-day programme. New to this year was the introduction of the Health Economics & Outcomes Research (HEOR) track and a dedicated poster area, designed to enhance the academic presence and deepen the discussions within the community.
Event Highlights
Keynote Speakers
Industry leaders sharing insights
Networking
Connect with professionals
Certification
Get certified upon completion
Refreshments
Food and drinks provided
.png){kind=logo}
